These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16868439)

  • 1. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.
    Parsons TD; Tucker KA; Hall CD; Robertson WT; Eron JJ; Fried MW; Robertson KR
    AIDS; 2006 Aug; 20(12):1591-5. PubMed ID: 16868439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
    Cooper CL; Mills E
    Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C; Alberola J; Tamarit A; Navarro D
    Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
    Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
    AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropsychological performance in patients with human inmunodeficiency (HIV) and hepatitis C virus (HCV) coinfection].
    Failde Garrido JM; Rodríguez Alvarez M; López Castro J; Simón López MA
    Neurologia; 2009 Apr; 24(3):154-9. PubMed ID: 19418290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
    Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
    HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infection.
    Cooper CL; Mills E; Angel JB
    AIDS; 2007 Jan; 21(1):71-6. PubMed ID: 17148970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.
    Ammassari A; Antinori A; Aloisi MS; Trotta MP; Murri R; Bartoli L; Monforte AD; Wu AW; Starace F
    Psychosomatics; 2004; 45(5):394-402. PubMed ID: 15345784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.
    Braitstein P; Montessori V; Chan K; Montaner JS; Schechter MT; O'Shaughnessy MV; Hogg RS
    AIDS Care; 2005 May; 17(4):505-15. PubMed ID: 16036236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment.
    Thein H; Maruff P; Krahn M; Kaldor J; Koorey Dj; Brew B; Dore G
    HIV Med; 2007 Apr; 8(3):192-202. PubMed ID: 17461864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
    HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation in HIV/hepatitis co-infection.
    Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
    J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
    Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad;
    AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive function profile in HIV-infected school-age children.
    Koekkoek S; de Sonneville LM; Wolfs TF; Licht R; Geelen SP
    Eur J Paediatr Neurol; 2008 Jul; 12(4):290-7. PubMed ID: 17950012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAART attenuates liver fibrosis in patients with HIV/HCV co-infection: fact or fiction?
    Verma S
    J Antimicrob Chemother; 2006 Sep; 58(3):496-501. PubMed ID: 16854955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
    Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
    Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-hepatitis C virus co-infection is associated with decreased plasmatic IL-7 levels.
    Soriano-Sarabia N; Vallejo A; Molina-Pinelo S; Genebat M; del Mar Rodríguez M; Sánchez-Quijano A; Martínez-Moya M; Vivancos J; Leal M
    AIDS; 2007 Jan; 21(2):253-5. PubMed ID: 17197823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
    Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P
    AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the factors involving in the development of hypothyroidism in HIV-infected patients: a case-control study.
    Afhami S; Haghpanah V; Heshmat R; Rasoulinejad M; Izadi M; Lashkari A; Tavangar SM; Hajiabdolbaghi M; Mohraz M; Larijani B
    Infection; 2007 Oct; 35(5):334-8. PubMed ID: 17885731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.
    Cysique LA; Maruff P; Brew BJ
    Neurology; 2006 May; 66(9):1447-50. PubMed ID: 16682686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.